The differences in those who responded to enteral phosphorus therapy versus those who worsened could not be explained by the differences in carbohydrate, caloric, or insulin intakes, arterial pH, presence of traumatic brain injury or other clinical or laboratory parameters (Table 3). This evidence concerns the gene INS and injury.